This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Roy Jacobs & Associates Files Class Action On Behalf Of Purchasers Of Alphatec Holdings, Inc. Securities ("ATEC")

Roy Jacobs & Associates announces that it has filed a class action complaint in the United States District Court for the Southern District of California on behalf of purchasers of the common stock of Alphatec Holdings, Inc. (“ATEC” or the “Company”) (NASDAQ: ATEC) during the period from December 18, 2009 through August 5, 2010, alleging claims for securities fraud pursuant to the federal securities laws. The Complaint was filed against ATEC and certain of its officers, directors and controlling persons.

For further information, please contact Roy L. Jacobs, Esq. toll-free at 1-888-884-4490 or by e-mail at, or visit our Website at, where you can obtain further information and join the action.

ATEC designs, develops, manufactures and markets products for the surgical treatment of spinal disorders. The Complaint alleges that on December 17, 2009, the Company announced that it was going to acquire Scient’x, S.A. (“Scient’x”) from HealthPointCapital Partners, L.P. and HealthPointCapital Partners II, L.P. (collectively, “HealthPointCapital”), which then owned 38% of ATEC’s shares, in an all stock transaction. With respect to the proposed transaction, the Company praised the Scient’x acquisition and announced that it expected 2010 pro forma full-year revenue of $220 million to $225 million, and adjusted EBITDA of $32 million to $35 million (the “Aggressive Projection”). On this news, ATEC shares rose 8%. ATEC reiterated the Aggressive Projection on February 23, 2010, April 12, 2010 and May 10, 2010.

As further alleged in the Complaint, these statements were made to increase interest in ATEC’s stock, so that ATEC and HealthPointCapital could sell off a significant number of their ATEC shares at the highest price possible in an upcoming offering. In fact, the statements were unrealistic because: (a) pricing pressures were steadily increasing; (b) ATEC planned to dispose of its Asian distributor without any realistic plan to replace the revenues the distributor produced; (c) Scient’x had exhibited almost no revenue growth in the first nine months of 2009, and its ability to market and sell in 2010 would be disrupted by any acquisition; and (d) integrating the two companies would be a long process, which would negatively affect 2010 revenues. On March 26, 2010, ATEC closed the Scient’x acquisition. On Aril 12, 2010, the Company announced a follow-on public offering, wherein ATEC and HealthPointCapital would each sell 8 million shares. The offering closed on April 21, 2010 and, with over-allotments, ATEC and HealthPointCapital each sold 9.2 million shares, for $46 million in gross proceeds.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
ATEC $1.45 2.84%
AAPL $124.43 -1.54%
FB $82.22 -1.18%
GOOG $548.00 -0.73%
TSLA $188.77 -0.94%


DOW 17,776.12 -200.19 -1.11%
S&P 500 2,067.89 -18.35 -0.88%
NASDAQ 4,900.8850 -46.5560 -0.94%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs